Alkem Laboratories Ltd shares fall 4.1% as Q1FY27 earnings and business updates disappoint.
Why did Alkem Laboratories Ltd shares fall today?
Alkem Laboratories Ltd shares experienced a decline of 4.1% today, trading at ₹5,196.75 as of 02:34 PM on Friday. The primary reason for this drop is the market's reaction to the company's financial results for the first quarter of fiscal year 2027 (Q1FY27), which were released today.
In its official press release, Alkem reported a healthy 11% growth in revenue for Q1FY27, describing it as a "steady note" to start the new financial year. The company highlighted strong performance in its India business, which outpaced the market, and encouraging growth in its non-US international markets. However, the managing director, Mr. Sandeep Singh, also candidly pointed out that there are specific areas where the company needs to improve. While the topline growth was positive, it appears that the market may have been focusing on these areas requiring improvement or perhaps had even higher expectations, leading to the sell-off in the shares.
What does Alkem Laboratories Ltd do?
Alkem Laboratories Ltd is a publicly listed company on Indian stock exchanges that reports quarterly financial results, including standalone and consolidated performance. The company provides business updates to investors and analysts as part of its financial disclosures. It is led by a Managing Director who comments on the company's operational and financial outcomes.
Alkem Laboratories Ltd Financials
In CroresAlkem Laboratories Ltd reported a quarterly revenue of ₹3736.82 Crores in December 2025, which declined to ₹3603.32 Crores in March 2026, representing a decrease of approximately ₹133.5 Crores or roughly 3.6%. The company's profit showed a more significant decline, dropping from ₹636.02 Crores in December 2025 to ₹236.46 Crores in March 2026 — a substantial fall of approximately ₹399.56 Crores, or about 62.8%. While the revenue experienced a moderate quarter-over-quarter contraction, the sharp decline in profit suggests that the company may have faced higher operating costs, increased expenses, or lower margins during the March 2026 quarter compared to the preceding one.
Alkem Laboratories Ltd Shareholding Pattern
Promoter holding stands at 49.7% of the total share capital. Foreign Institutional Investors (FIIs) hold 10.42% stake in the company, while Domestic Institutional Investors (DIIs) hold 22.64%. Public shareholders hold the remaining 17.25% stake in Alkem Laboratories Ltd.
Alkem Laboratories Ltd FAQs
Q: Why did Alkem shares fall 4.1% today?
Pl find enclosed press release and analyst presentation on Q1FY27 earnings and business updates of the Company. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Alkem Laboratories Ltd?
As per the latest data, promoters hold 49.7% stake in Alkem Laboratories Ltd, while FII holding stands at 10.42%. Domestic institutional investors hold 22.64%, and public shareholders account for 17.25% of the equity.
Q: What is the current stock price of Alkem Laboratories Ltd?
Alkem Laboratories Ltd shares are currently trading at ₹5196.75, recording a decline of 4.1% from the previous close.
Q: What is the market capitalization of Alkem Laboratories Ltd?
The company currently has a market capitalization of ₹62134.94 crore, reflecting its valuation in the Indian equity market.